inovmedИнновационная медицина КубаниInnovative Medicine of Kuban2541-9897Scientific Research Institute – Ochapovsky Regional Clinical Hospital No. 1inovmed-106Research ArticleЛЕКЦИИLECTURESКЛАССИФИКАЦИЯ ОПУХОЛЕЙ ЩИТОВИДНОЙ ЖЕЛЕЗЫ (ВОЗ, 2017): АКЦЕНТ НА ПРОГНОЗCLASSIFICATION FOR THYROID GLAND TUMORS (WHO, 2017): ATTENTION TO PROGNOSTIC FACTORSПонкинаО. Н.PonkinaO. N.ponkina_olga@mail.ruНаучно-исследовательский институт – Краевая клиническая больница № 1 им. проф. С.В. Очаповского Министерства здравоохранения Краснодарского краяРоссияScientific Research Institute – Ochapovsky Regional Clinical Hospital no. 1, The Krasnodar Krai Ministry of HealthRussian Federation201730122017845359Copyright © Понкина О.Н., 20172017Понкина О.Н.Ponkina O.N.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.innovmedkub.ru/jour/article/view/106

В статье представлены основные изменения Классификации опухолей щитовидной железы четвертого пересмотра (ВОЗ, 2017) в сравнении с пересмотром 2004 г. Выделены наиболее существенные из них: 1) группы «другие инкапсулированные опухоли щитовидной железы с фолликулярным паттерном» отнесены к категории пограничных опухолей и включают следующие понятия: фолликулярная опухоль неопределенного злокачественного потенциала (FT-UMP), высокодифференцированная опухоль неопределенного злокачественного потенциала (WDT-UMP) и неинвазивная фолликулярная опухоль с папиллярно-ядерными свойствами (NIFTP); 2) онкоцитарные опухоли, ранее рассматриваемые в группе фолликулярных аденом/карцином, определены как отдельный вид опухолей, имеющий самостоятельную биологическую сущность.

In this article we presented four main changes in the Classification for Thyroid Gland Tumors, the fourth revision (WHO, 2017) regarding the revision presented in 2004. The most essential of them are: 1) defining the «other encapsulated tumors of thyroid gland with a follicular pattem» group which are referred to the category containing boundary tumors and includes the following concepts: a follicular tumor of the uncertain malignant potential (FT-UMP), the high-differentiated tumor of the uncertain malignant potential (WDT-UMP) and a noninvasive follicular tumor with papillary and nuclear properties (NIFTP) and 2) the oncocytic tumors which were earlier considered in group of follicular adenomas / carcinomas are defined as a separate type of tumors with an independent biological entity.

классификация ВОЗопухолищитовидная железаWHO classificationtumorsthyroid glandReferencesLloyd R.V., Osamura R.Y., Klоppel G., Rosai J. WHO Classification of Tumors: Pathology and Genetics of Tumors of Endocrine Organs. 4th ed. Lyon, France: IARC Press. 2017. 66-143Lloyd R.V., Osamura R.Y., Klоppel G., Rosai J. WHO Classification of Tumors: Pathology and Genetics of Tumors of Endocrine Organs. 4th ed. Lyon, France: IARC Press. 2017. 66-143Nikiforov Y.E., Baloch Z.W., Beige G., et al. Follicular adenoma. In: Lloyd R.V., Osamura R.Y., Klоppel G., Rosai J. WHO Classification of Tumors: Pathology and Genetics of Tumors of Endocrine Organs. 4th ed. Lyon, France: IARC Press; 2017: 69-72.Nikiforov Y.E., Baloch Z.W., Beige G., et al. Follicular adenoma. In: Lloyd R.V., Osamura R.Y., Klоppel G., Rosai J. WHO Classification of Tumors: Pathology and Genetics of Tumors of Endocrine Organs. 4th ed. Lyon, France: IARC Press; 2017: 69-72.Carney J.A., Hirokawa M., Lloyd R.V., et al. Hyalinizing trabecular tumors of the thyroid gland are almost all benign. Am. J. Surg. Pathol. 2008; 32: 1877-1889.Carney J.A., Hirokawa M., Lloyd R.V., et al. Hyalinizing trabecular tumors of the thyroid gland are almost all benign. Am. J. Surg. Pathol. 2008; 32: 1877-1889.Chan J.K.C., Nikiforov Y.Y., Tallini G. Other encapsulated follicular-patterned thyroid tumors. In: Lloyd R.V., Osamura R.Y., Klоppel G., Rosai J. WHO Classification of Tumors: Pathology and Genetics of Tumors of Endocrine Organs. 4th ed. Lyon, France: IARC Press; 2017: 72.Chan J.K.C., Nikiforov Y.Y., Tallini G. Other encapsulated follicular-patterned thyroid tumors. In: Lloyd R.V., Osamura R.Y., Klоppel G., Rosai J. WHO Classification of Tumors: Pathology and Genetics of Tumors of Endocrine Organs. 4th ed. Lyon, France: IARC Press; 2017: 72.Nikiforov Y.E., Seethala R.R., Tallini G., et al. Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma: a paradigm shift to reduce overtreatment of indolent tumors. JAMA oncology. 2016; 2(8): 1023-1029.Nikiforov Y.E., Seethala R.R., Tallini G., et al. Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma: a paradigm shift to reduce overtreatment of indolent tumors. JAMA oncology. 2016; 2(8): 1023-1029.Seethala R.R., Asa S.L., Bullock M.J., Carty S.E., Hodak S.P., McHugh J.B., Nikiforov Y.E., Pettus J., Richardson M.S., Shah J.; Thompson L.D.R. Protocol for the Examination of Specimens From Patients With Carcinomas of the Thyroid Gland. College of American Pathologist 2017. Available at: http://www.CAP.org.Seethala R.R., Asa S.L., Bullock M.J., Carty S.E., Hodak S.P., McHugh J.B., Nikiforov Y.E., Pettus J., Richardson M.S., Shah J.; Thompson L.D.R. Protocol for the Examination of Specimens From Patients With Carcinomas of the Thyroid Gland. College of American Pathologist 2017. Available at: http://www.CAP.org.Cancer Genome Atlas Research Network. Integrated genomic characterization of pappilary thyroid carcinoma. Cell. 2014; 159: 676-90.Cancer Genome Atlas Research Network. Integrated genomic characterization of pappilary thyroid carcinoma. Cell. 2014; 159: 676-90.Lam A.K. Pathology of Endocrine Tumors Update: Word Healh Organization New Classification 2017 -Other Thyroid Tumors. AJSP: Reviews&Reports. 2017; 22(4): 209-216.Lam A.K. Pathology of Endocrine Tumors Update: Word Healh Organization New Classification 2017 -Other Thyroid Tumors. AJSP: Reviews&Reports. 2017; 22(4): 209-216.Morris L.G., Shaha A.R., Tuttle R.M., Sikora A.G., Ganly I. Tall-cell variant of papillary thyroid carcinoma: a matched-pair analysis of survival. Thyroid. 2010; 20(2): 153-158.Morris L.G., Shaha A.R., Tuttle R.M., Sikora A.G., Ganly I. Tall-cell variant of papillary thyroid carcinoma: a matched-pair analysis of survival. Thyroid. 2010; 20(2): 153-158.Nikiforov Y.E., Nikiforova M.N. Molecular genetics and diagnosis of thyroid cancer. Nat. Rev. Endocrinol. 2011; 7(10): 569-580.Nikiforov Y.E., Nikiforova M.N. Molecular genetics and diagnosis of thyroid cancer. Nat. Rev. Endocrinol. 2011; 7(10): 569-580.Cameselle-Teijeiro J., Chan J.K. Cribriform-morular variant of papillary carcinoma: a distinctive variant representing the sporadic counterpart of familial adenomatous polyposis-associated thyroid carcinoma? Mod. Pathol. 1999; 12(4): 400-411.Cameselle-Teijeiro J., Chan J.K. Cribriform-morular variant of papillary carcinoma: a distinctive variant representing the sporadic counterpart of familial adenomatous polyposis-associated thyroid carcinoma? Mod. Pathol. 1999; 12(4): 400-411.Regalbuto C., Malandrino P., Tumminia A., Le Moli R., Vigneri R., Pezzino V. A diffuse sclerosing variant of papillary thyroid carcinoma: clinical and pathologic features and outcomes of 34 consecutive cases. Thyroid. 2011; 21(4): 383-389.Regalbuto C., Malandrino P., Tumminia A., Le Moli R., Vigneri R., Pezzino V. A diffuse sclerosing variant of papillary thyroid carcinoma: clinical and pathologic features and outcomes of 34 consecutive cases. Thyroid. 2011; 21(4): 383-389.Rivera M., Tuttle R.M., Patel S., Shaha A., Shah J.P., Ghossein R.A. Encapsulated papillary thyroid carcinoma: a clinico-pathologic study of 106 cases with emphasis on its morphologic subtypes (histologic growth pattern). Thyroid. 2009; 19(2): 119-127.Rivera M., Tuttle R.M., Patel S., Shaha A., Shah J.P., Ghossein R.A. Encapsulated papillary thyroid carcinoma: a clinico-pathologic study of 106 cases with emphasis on its morphologic subtypes (histologic growth pattern). Thyroid. 2009; 19(2): 119-127.Liu J., Singh B., Tallini G., et al. Follicular variant of papillary thyroid carcinoma: a clinicopathologic study of a problematic entity. Cancer. 2006; 107(6): 1255 -1264.Liu J., Singh B., Tallini G., et al. Follicular variant of papillary thyroid carcinoma: a clinicopathologic study of a problematic entity. Cancer. 2006; 107(6): 1255 -1264.Bernstein J., Virk R.K., Hui P., et al. Tall-cell variant of papillary thyroid microcarcinoma: clinicopathologic features with BRAF (V600E) mutational analysis. Thyroid. 2013; 23: 1525-31.Bernstein J., Virk R.K., Hui P., et al. Tall-cell variant of papillary thyroid microcarcinoma: clinicopathologic features with BRAF (V600E) mutational analysis. Thyroid. 2013; 23: 1525-31.Chan J.K. The thyroid gland. In: Fletcher CDM, ed. Diagnostic Histopathology of Tumours. Edinburgh: Churchill Livingstone Elsevier. 2007: 1018.Chan J.K. The thyroid gland. In: Fletcher CDM, ed. Diagnostic Histopathology of Tumours. Edinburgh: Churchill Livingstone Elsevier. 2007: 1018.Nikiforov Y.E., Ohori N.P. Follicular carcinoma. In: Nikiforov YE, Biddinger PW, Thompson LDR, eds. Diagnostic Pathology and Molecular Genetics of the Thyroid. 2nd ed. Philadelphia, PA: Lippincott Williams and Wilkins. 2012: 152- 182.Nikiforov Y.E., Ohori N.P. Follicular carcinoma. In: Nikiforov YE, Biddinger PW, Thompson LDR, eds. Diagnostic Pathology and Molecular Genetics of the Thyroid. 2nd ed. Philadelphia, PA: Lippincott Williams and Wilkins. 2012: 152- 182.Ganly I., Filho R.J., et al. Genomic dissection of Hurthle cell carcinoma reveals a unique class of thyroid malignancy. J. Clin. Endocrinol. Metab. 2013; 98: 962-972.Ganly I., Filho R.J., et al. Genomic dissection of Hurthle cell carcinoma reveals a unique class of thyroid malignancy. J. Clin. Endocrinol. Metab. 2013; 98: 962-972.Volante M., Collini P., Nikiforov Y.E., et al. Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach. Am. J. Surg. Pathol. 2007; 31(8): 1256-1264.Volante M., Collini P., Nikiforov Y.E., et al. Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach. Am. J. Surg. Pathol. 2007; 31(8): 1256-1264.Dettmer M., Schmitt A., Steinert H., et al. Poorly differentiated thyroid carcinomas: how much poorly differentiated is needed? Am. J. Surg. Pathol. 2011; 35(12): 1866-1872.Dettmer M., Schmitt A., Steinert H., et al. Poorly differentiated thyroid carcinomas: how much poorly differentiated is needed? Am. J. Surg. Pathol. 2011; 35(12): 1866-1872.Hiltzik D., Carlson D.L., Tuttle R.M., et al. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients. Cancer. 2006; 106(6): 1286-1295.Hiltzik D., Carlson D.L., Tuttle R.M., et al. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients. Cancer. 2006; 106(6): 1286-1295.Nikiforov Y.E., Seethala R.R. Anaplastic (undifferentiated) carcinoma. In: Nikiforov YE, Biddinger PW, Thompson LDR., eds. Diagnostic Pathology and Molecular Genetics of the Thyroid. 2nd ed. Philadelphia, PA: Lippincott Williams and Wilkins. 2012: 263-284.Nikiforov Y.E., Seethala R.R. Anaplastic (undifferentiated) carcinoma. In: Nikiforov YE, Biddinger PW, Thompson LDR., eds. Diagnostic Pathology and Molecular Genetics of the Thyroid. 2nd ed. Philadelphia, PA: Lippincott Williams and Wilkins. 2012: 263-284.DeLellis R.A., Mangray S. Medullary Thyroid Carcinoma: A Contemporary Perspective. AJSP: Reviews&Reports. 2017; 22(4): 196-208.DeLellis R.A., Mangray S. Medullary Thyroid Carcinoma: A Contemporary Perspective. AJSP: Reviews&Reports. 2017; 22(4): 196-208.

The authors declare that there are no conflicts of interest present.